How do pediatric patients perceive adverse drug events of anticonvulsant drugs? A survey

被引:6
|
作者
Neininger, Martina Patrizia [1 ,2 ]
Woltermann, Sarah [1 ,2 ,3 ]
Jeschke, Sarah [4 ]
Herziger, Birthe [4 ]
Mueller, Ruth Melinda [4 ]
Kiess, Wieland [3 ]
Bertsche, Thilo [1 ,2 ]
Bertsche, Astrid [3 ,4 ]
机构
[1] Univ Leipzig, Med Fac, Inst Pharm, Drug Safety Ctr, Bruderstr 32, D-04103 Leipzig, Germany
[2] Univ Leipzig, Med Fac, Inst Pharm, Clin Pharm, Bruderstr 32, D-04103 Leipzig, Germany
[3] Univ Hosp Children & Adolescents, Ctr Pediat Res, Liebigstr 20a, D-04103 Leipzig, Germany
[4] Univ Hosp Children & Adolescents, Neuropaediat, Ernst Heydemann Str 8, D-18057 Rostock, Germany
关键词
Adverse drug events (ADEs); Anticonvulsants; Children; Adolescents; Perceptions; Interview; SUDDEN UNEXPECTED DEATH; QUALITY-OF-LIFE; ANTIEPILEPTIC DRUGS; WEIGHT-GAIN; EPILEPSY; CHILDREN; ADOLESCENTS; OXCARBAZEPINE; VALPROATE; FEAR;
D O I
10.1007/s00431-020-03571-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Anticonvulsant drugs have a high risk of adverse drug events. Little is known about the perception of those events by pediatric patients. We performed a survey in the neuropediatric departments of two university hospitals. Using a questionnaire, we interviewed patients aged 6-18 years with current anticonvulsant treatment regarding (i) their fears about potential adverse drug events, (ii) experienced adverse drug events, and (iii) perceived burden of experienced adverse drug events. One hundred patients took part in the interview. (i) 40 (40%) expressed fears that the medication could harm them. Eighteen of 40 (45%) named fears concerning specific adverse drug events. Of those, 12/18 (67%) feared neurologic or psychiatric symptoms. (ii) 37 (37%) of children described altogether 60 experienced adverse drug events. Of those, 38 (63%) concerned neurologic or psychiatric symptoms. (iii) 32/37 (82%) children who experienced adverse drug events felt bothered by the experienced event. Among others, they described an emotional burden (11/37, 30%), and restrictions in school performance (8/37, 22%) and favorite leisure activities (4/37, 11%). Conclusion: School-aged children are well able to describe adverse drug events of their anticonvulsant medication. Almost two thirds of the described events concern neurologic or psychiatric symptoms that cause an emotional burden and restrictions according to the patients. What is Known: center dot Anticonvulsants have a high potential of adverse drug events. center dot In an earlier survey, parents expressed fears of severe adverse drug events such as liver failure, which seldom occur, and reported a high number of neurological and psychological adverse drug events. What is New: center dot Many children fear that their anticonvulsants could harm them, and they fear and experience neurological and psychological adverse drug events. center dot According to the children, adverse drug events cause an emotional burden and restrictions in school performance and favorite leisure activities.
引用
下载
收藏
页码:1413 / 1420
页数:8
相关论文
共 50 条
  • [21] Unexpected drug interactions and adverse events with antiretroviral drugs
    Moyle, G
    Boffito, M
    LANCET, 2004, 364 (9428): : 8 - 10
  • [22] Specificity of trigger drugs as indicators of adverse drug events
    Boon, G.
    Morse, S.
    Cavell, G.
    PHARMACY WORLD & SCIENCE, 2007, 29 (03): : 281 - 283
  • [23] Specificity of trigger drugs as indicators of adverse drug events
    Boon, G.
    Morse, S.
    Cavell, G.
    PHARMACY WORLD & SCIENCE, 2008, 30 (04): : 416 - 417
  • [24] MAJOR DIFFERENCES IN ADVERSE EVENTS WITH ANTIPSYCHOTIC DRUGS BETWEEN PEDIATRIC AND ADULT PATIENTS.
    Liu, X.
    Schuette, P.
    Green, D.
    La, J.
    Burnham, J.
    van den Anker, J.
    Huang, S.
    Burckart, G. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S42 - S43
  • [25] Database of adverse events associated with drugs and drug combinations
    Poleksic, Aleksandar
    Xie, Lei
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [26] How Do Patients with Heart Failure Perceive Their Symptoms?
    Lee, Solim
    Nolan, Amy
    Guerin, Julie
    Koons, Brittany
    Matura, Lea Ann
    Jurgens, Corrine Y.
    Dickson, Victoria V.
    Riegel, Barbara
    CIRCULATION, 2021, 144
  • [27] Incidence and impact of adverse drug events in pediatric inpatients
    Holdsworth, MT
    Fichtl, RE
    Behta, M
    Raisch, DW
    Mendez-Rico, E
    Adams, A
    Greifer, M
    Bostwick, S
    Greenwald, BM
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2003, 157 (01): : 60 - 65
  • [28] Computerized Surveillance for Adverse Drug Events in a Pediatric Hospital
    Kilbridge, Peter M.
    Noirot, Laura A.
    Reichley, Richard M.
    Berchelmann, Kathleen M.
    Schneider, Cortney
    Heard, Kevin M.
    Nelson, Miranda
    Bailey, Thomas C.
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2009, 16 (05) : 607 - 612
  • [29] Medication errors and adverse drug events in pediatric inpatients
    Kaushal, R
    Bates, DW
    Landrigan, C
    McKenna, DJ
    Clapp, MD
    Federico, F
    Goldmann, DA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16): : 2114 - 2120
  • [30] Adverse drug events in hospitalized patients
    Raschetti, R
    MennitiIppolito, F
    Morgutti, M
    Belisari, A
    Rossignoli, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (17): : 1351 - 1352